A new study from the Dana-Farber Cancer Institute found Black and Hispanic patients over 65 received fewer opioids for pain relief near the end of their lives than white patients.
A new study from the Dana-Farber Cancer Institute found Black and Hispanic patients over 65 received fewer opioids for pain relief near the end of their lives than white patients.